Drugs Targeting Cerebrovascular and Neurological Diseases via Green Solid Lipid Nanoparticles

This paper explores the development of inexperienced strong lipid nanoparticles (SLNs) utilizing fatty acid coacervation as a singular method for nasal drug transport, specially focused on cerebrovascular and neurological diseases. This technique leverages the biocompatibility and biodegradability of fatty acids, offering a sustainable and powerful drug transport system.SLNs facilitate direct delivery to the brain via nasal administration, bypassing the blood-mind barrier. Characterization famous most fulfilling particle length and drug release profiles. In vitro and in vivo studies exhibit stepped forward therapeutic consequences in neurological disorders. This approach offers a promising platform for centered, powerful remedy, promoting further clinical studies and development.